Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes
- 31 January 2005
- journal article
- research article
- Published by Elsevier BV in Lung Cancer
- Vol. 47 (1), 69-80
- https://doi.org/10.1016/j.lungcan.2004.10.014
Abstract
No abstract availableThis publication has 43 references indexed in Scilit:
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trialLung Cancer, 2003
- O-220 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trialLung Cancer, 2003
- National Institutes of Health Consensus Development Conference Statement: Adjuvant Therapy for Breast Cancer, November 1-3, 2000JNCI Journal of the National Cancer Institute, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Superiority of three-drug combination chemotherapy versus cisplatin-etoposide in advanced non-small cell lung cancer: a randomized trial by the italian oncology group for clinical researchLung Cancer, 1995
- Meta-analysis of randomised trials of systemic chemotherapy versus supportive treatment in non-resectable non-small cell lung cancerLung Cancer, 1995
- Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancerEuropean Journal of Cancer, 1994
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986